Radhika Jaiswal, Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4327 Barnett Rd, Wichita Falls, TX 76310 Phone: 940-764-5350 Fax: 940-764-5351 |
Dr. Rajesh Atluri, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1619 Midwestern Pkwy, Wichita Falls, TX 76302 Phone: 940-689-8900 Fax: 940-689-8901 |
John Caras, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 4003 Call Field Rd., Wichita Falls, TX 76308 Phone: 940-766-3600 Fax: 940-766-3610 |
Kimberley A Bourne-arriaga, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4327 Barnett Rd, Wichita Falls, TX 76310 Phone: 940-764-5350 |
News Archive
Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.
September 19-25 is National Prostate Cancer Awareness Week. If you are planning a story on prostate cancer, a disease that's diagnosed in more than 200,000 American men each year, please consider calling on experts from the Johns Hopkins Brady Urological Institute.
Cancer Research UK scientists are investigating whether beta-blockers hold the key to preventing breast cancer spread and improving survival. Promising early results will be presented on the eve of breast cancer awareness month at the Royal Society of Medicine.
Today's early morning highlights from the major news organizations, including reports about a new "Obamacare" ad in the Arkansas Senate race and a California poll measuring how the state's voters feel about a ballot initiative that would expand the state's ability to regulate health insurance rates.
According to SDI's Pharmaceutical Company Image 2011 study, obstetricians/gynecologists ranked Pfizer No. 1 overall. Forty percent of the 325 participating OB/GYNs reported that Pfizer was one of the three companies they held in highest esteem. In the 2010 study, Pfizer placed second.
› Verified 7 days ago